tiprankstipranks
Trending News
More News >
Hcw Biologics, Inc. (HCWB)
NASDAQ:HCWB
US Market

HCW Biologics (HCWB) Financial Statements

Compare
190 Followers

HCW Biologics Financial Overview

HCW Biologics's market cap is currently $3.30M. The company's EPS TTM is $-4.13; its P/E ratio is -0.09; HCW Biologics is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-0.84. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 2.57M$ 2.84M$ 6.72M$ 0.00$ 4.10M
Gross Profit$ 959.40K$ 560.36K$ 2.59M$ -543.60K$ 4.10M
Operating Income$ -29.48M$ -25.72M$ -15.08M$ -13.37M$ -5.82M
EBITDA$ -27.68M$ -23.58M$ -14.06M$ -12.32M$ -5.25M
Net Income$ -30.02M$ -24.99M$ -14.90M$ -12.86M$ -5.78M
Balance Sheet
Cash & Short-Term Investments$ 4.67M$ 3.60M$ 32.06M$ 36.71M$ 8.46M
Total Assets$ 30.24M$ 28.51M$ 46.81M$ 53.51M$ 15.40M
Total Debt$ 13.69M$ 6.30M$ 6.41M$ 0.00$ 567.31K
Net Debt$ 9.02M$ 2.71M$ -15.92M$ -11.73M$ -7.89M
Total Liabilities$ 37.01M$ 15.05M$ 9.38M$ 2.32M$ 1.00M
Stockholders' Equity$ -6.77M$ 13.46M$ 37.43M$ 51.19M$ 14.40M
Cash Flow
Free Cash Flow$ -14.49M$ -28.72M$ -20.66M$ -11.02M$ -10.62M
Operating Cash Flow$ -14.23M$ -22.51M$ -10.39M$ -10.98M$ -10.43M
Investing Cash Flow$ -261.62K$ 3.80M$ 14.71M$ -35.02M$ -186.68K
Financing Cash Flow$ 15.57M$ -14.53K$ 6.27M$ 49.27M$ 11.72M
Currency in USD

HCW Biologics Earnings and Revenue History

HCW Biologics Debt to Assets

HCW Biologics Cash Flow

HCW Biologics Forecast EPS vs Actual EPS